The motivation for this research was the study of a medical cost data set from a clinical trial. If a Regulatory Body were to be accept the new intervention that has been proposed then a Health Care provider has to budget for future treatments for some members of the rest of the population. In this Bayesian analysis we want to be able to calculate the expected value for one unobserved member of this finite population from its posterior predictive distribution by firstly establishing the parametric data model that best captures the positive skew characteristics of the costs. We then develop a novel approach to modelling the priors that enable an expert's prior beliefs to be elicited while permitting a limited analytical study of the model. T...
Most published research on the comparison between medical treatment options merely compares the resu...
In a probabilistic sensitivity analysis (PSA) of a cost-effectiveness (CE) study, the unknown parame...
We consider the problem of assessing new and existing technologies for their cost-effectiveness in t...
The motivation for this research was the study of a medical cost data set from a clinical trial. If ...
The Bayesian approach to statistics has been growing rapidly in popularity as an alternative to the ...
We consider the problem of assessing new and existing technologies for their cost-effectiveness in ...
Estimation of the extra cost that is required to improve the efficacy of a treatment is an important...
We consider the problem of assessing new and existing technologies for their cost-effectiveness in t...
We consider the problem of assessing new and existing technologies for their cost-effectiveness in t...
The development of Bayesian statistical methods for the assessment of the cost-effectiveness of heal...
The purpose of this dissertation is to analyze three models in medicine and finance using Bayesian i...
The aim of this paper is to discuss the use of Bayesian methods in cost-effectiveness analysis (CEA)...
We consider the problem of assessing new and existing technologies for their cost-effectiveness in ...
The National Institute for Health and Clinical Excellence (NICE) is responsible for making recomme...
Most published research on the comparison between medical treatment options merely compares the resu...
Most published research on the comparison between medical treatment options merely compares the resu...
In a probabilistic sensitivity analysis (PSA) of a cost-effectiveness (CE) study, the unknown parame...
We consider the problem of assessing new and existing technologies for their cost-effectiveness in t...
The motivation for this research was the study of a medical cost data set from a clinical trial. If ...
The Bayesian approach to statistics has been growing rapidly in popularity as an alternative to the ...
We consider the problem of assessing new and existing technologies for their cost-effectiveness in ...
Estimation of the extra cost that is required to improve the efficacy of a treatment is an important...
We consider the problem of assessing new and existing technologies for their cost-effectiveness in t...
We consider the problem of assessing new and existing technologies for their cost-effectiveness in t...
The development of Bayesian statistical methods for the assessment of the cost-effectiveness of heal...
The purpose of this dissertation is to analyze three models in medicine and finance using Bayesian i...
The aim of this paper is to discuss the use of Bayesian methods in cost-effectiveness analysis (CEA)...
We consider the problem of assessing new and existing technologies for their cost-effectiveness in ...
The National Institute for Health and Clinical Excellence (NICE) is responsible for making recomme...
Most published research on the comparison between medical treatment options merely compares the resu...
Most published research on the comparison between medical treatment options merely compares the resu...
In a probabilistic sensitivity analysis (PSA) of a cost-effectiveness (CE) study, the unknown parame...
We consider the problem of assessing new and existing technologies for their cost-effectiveness in t...